Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
6.18
+0.03 (0.49%)
At close: Nov 14, 2025, 4:00 PM EST
6.06
-0.12 (-1.94%)
After-hours: Nov 14, 2025, 5:23 PM EST

Kezar Life Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
--7---
Upgrade
Cost of Revenue
65.7465.7485.751.0138.94-
Upgrade
Gross Profit
-65.74-65.74-78.7-51.01-38.94-
Upgrade
Selling, General & Admin
20.8123.3926.5420.1515.7211.97
Upgrade
Research & Development
-21.04----30.98
Upgrade
Operating Expenses
-0.2223.3926.5420.1515.7242.95
Upgrade
Operating Income
-65.52-89.14-105.24-71.16-54.66-42.95
Upgrade
Interest Expense
-1.58-1.59-1.55-1.19-0.16-
Upgrade
Interest & Investment Income
5.388.4611.14.110.191.21
Upgrade
EBT Excluding Unusual Items
-61.72-82.27-95.68-68.24-54.63-41.74
Upgrade
Merger & Restructuring Charges
0.01-1.47-6.19---
Upgrade
Pretax Income
-61.71-83.74-101.87-68.24-54.63-41.74
Upgrade
Net Income
-61.71-83.74-101.87-68.24-54.63-41.74
Upgrade
Net Income to Common
-61.71-83.74-101.87-68.24-54.63-41.74
Upgrade
Shares Outstanding (Basic)
777754
Upgrade
Shares Outstanding (Diluted)
777754
Upgrade
Shares Change (YoY)
0.36%0.48%7.70%27.69%19.90%130.58%
Upgrade
EPS (Basic)
-8.44-11.49-14.04-10.13-10.35-9.49
Upgrade
EPS (Diluted)
-8.44-11.49-14.04-10.13-10.35-9.49
Upgrade
Free Cash Flow
-56.66-74.24-83.46-60.42-42.75-37.14
Upgrade
Free Cash Flow Per Share
-7.75-10.18-11.50-8.97-8.10-8.44
Upgrade
Operating Margin
---1503.39%---
Upgrade
Profit Margin
---1455.29%---
Upgrade
Free Cash Flow Margin
---1192.21%---
Upgrade
EBITDA
-64.54-88.1-104.17-70.14-53.15-41.41
Upgrade
D&A For EBITDA
0.981.041.071.021.511.54
Upgrade
EBIT
-65.52-89.14-105.24-71.16-54.66-42.95
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q